Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
0.1%
1w
0.6%
1m
12.1%
3m
18.1%
6m
36.4%
1y
57.4%
all
83.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 2,128 0.1%
1,748
2,410
Company Overview
Sales
1,086 Cr
Growth: 14.8%
Profit after Tax
328 Cr
Growth: 4.7%
Mid Cap
22,257 Cr
P/E: 67.9x
Industry P/E: 37.3x
Fundamentals
Sales (Cr) ₹ 1,086
Growth 14.8%
EBITDA 42.2%
P/S 20.5x
Dividend 0.0%
P/E 67.9x
Book Value ₹ 161
PEG Ratio 4.6x
ROE 20.8%
P/B 13.2x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (15 Indices) view more